Home > Products > CD16 & HER2
> Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (scIgG)
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (scIgG) (CAT#: SCIGG-038)
Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD16 and anti-HER2 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD16 x Anti-HER2 Bispecific Antibody (scIgG) (SCIGG-038). Click the button below to contact us or submit your feedback about this product.